Diagnostic criteria for primary progressive multiple sclerosis: A position paper

The unique clinical characteristics of primary progressive multiple sclerosis (PPMS) pose particular diagnostic difficulties, both in excluding other causes of progressive syndromes and in confirming the diagnosis of MS, which is not adequately addressed by current diagnostic criteria. This article presents new diagnostic criteria developed by a group of investigators on the basis of a review of their considerable experience with PPMS. (We conclude that at least 1 year of clinical progression must be documented before a diagnosis of PPMS is made.) Three levels of diagnostic certainty have been defined—definite, probable, and possible—based on clinical findings, abnormal cerebrospinal fluid, abnormalities on magnetic resonance imaging (MRI) of the brain and spinal cord, and evoked potentials. In definite PPMS, evidence of intrathecal synthesis of immunoglobulin G together with one of the following three MRI criteria is required: (1) nine brain lesions, (2) two spinal cord lesions, or (3) four to eight brain lesions and one spinal cord lesion. Preliminary testing of these criteria was carried out on a cohort of 156 patients participating in a European natural history study of PPMS: 64% fulfilled the criteria for definite PPMS, 35% for probable PPMS, and only 1% for possible PPMS. These criteria now require prospective validation in a cohort of newly diagnosed patients and by postmortem examination. Ann Neurol 2000;47:831–835

[1]  B. Weinshenker Progressive forms of MS: classification streamlined or consensus overturned? , 2000, The Lancet.

[2]  J. Whitaker,et al.  Clinical and laboratory features of primary progressive and secondary progressive MS , 1999, Neurology.

[3]  A. Thompson,et al.  Problems in designing and recruiting to therapeutic trials in primary progressive multiple sclerosis , 1999, Journal of Neurology.

[4]  J. Baskerville,et al.  The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.

[5]  F. Barkhof,et al.  Primary and transitional progressive MS , 1999, Neurology.

[6]  S. Straus Bridging the gulf in war syndromes , 1999, The Lancet.

[7]  J A Frank,et al.  Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis , 1998, Annals of neurology.

[8]  G. McDonnell,et al.  Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK , 1998, Journal of neurology, neurosurgery, and psychiatry.

[9]  G. Comi,et al.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. , 1997, Brain : a journal of neurology.

[10]  A J Thompson,et al.  PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS , 1997 .

[11]  A. Thompson,et al.  Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. , 1996, Brain : a journal of neurology.

[12]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[13]  W. Mcdonald,et al.  A study of oligoclonal band negative multiple sclerosis. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[14]  Patients with clinically definite multiple sclerosis, white matter abnormalities on MRI, and normal CSF: if not multiple sclerosis, what is it? , 1995, Journal of neurology, neurosurgery, and psychiatry.

[15]  G. Bernardi,et al.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[16]  R. Schiffer,et al.  Multiple sclerosis. The problem of incorrect diagnosis. , 1986, Archives of neurology.

[17]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[18]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[19]  W. Mcdonald,et al.  Diagnosis and classification of multiple sclerosis. , 1977, British medical bulletin.

[20]  F. Mcdowell,et al.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS , 1965, Annals of the New York Academy of Sciences.